KMTS

SEC source: 0001193125-26-257911 · ownership.xml · nonDerivative · entry 1

Mahboob Vaseem · CIK 0001655157 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,961

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. ("Common Share"). Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.

F2 · balance_after: Includes 5,837 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.

SEC source: 0001193125-26-257908 · ownership.xml · nonDerivative · entry 1

Umberger Traci S · CIK 0001877198 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,860

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.

SEC source: 0001193125-26-257907 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,467

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.

SEC source: 0001193125-26-229188 · ownership.xml · nonDerivative · entry 2

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,786

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $21.2433 to $21.6300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-229188 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 341,631

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.2200 to $20.2115. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-159276 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 349,786

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.2200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-132324 · ownership.xml · nonDerivative · entry 1

COHEN RAYMOND W · CIK 0001258288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,903

F1 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $19.82 to $20.02. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-115983 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 364,786

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.7709. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-104188 · ownership.xml · nonDerivative · entry 1

Reilly Kevin C · CIK 0001958127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,300

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

SEC source: 0001193125-26-059532 · ownership.xml · nonDerivative · entry 3

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 379,786

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.0771 to $27.1800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-059532 · ownership.xml · nonDerivative · entry 2

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 379,879

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.0200 to $26.9998. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-059532 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 383,151

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $25.0150 to $26.0100. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-26-015862 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 394,786

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2800 to $23.1340. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

SEC source: 0001193125-25-338326 · ownership.xml · nonDerivative · entry 1

Umberger Traci S · CIK 0001877198 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,633

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.51 to $26.96. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

F3 · balance_after: Includes 12,797 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.

SEC source: 0001193125-25-338322 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 409,786

F1 · kind: The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.390 to $26.9504. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

F3 · balance_after: Includes 27,209 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.

SEC source: 0001193125-25-308424 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,557

F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date.

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date.

SEC source: 0000950170-25-113628 · ownership.xml · nonDerivative · entry 1

Hanley Conor · CIK 0002072296 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,120

F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. 2,212 RSUs will vest on June 4, 2026 and 10,908 RSUs will vest on September 4, 2026, in each case subject to the Reporting Person's continued service through such date.

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. 2,212 RSUs will vest on June 4, 2026 and 10,908 RSUs will vest on September 4, 2026, in each case subject to the Reporting Person's continued service through such date.

SEC source: 0000950170-25-113627 · ownership.xml · nonDerivative · entry 1

Schwartz Jeffrey Lawrence · CIK 0001702957 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,909

F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

SEC source: 0000950170-25-113637 · ownership.xml · nonDerivative · entry 1

Ladone Mary Kay · CIK 0001760737 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,903

F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

F2 · balance_after: Includes 12,994 restricted common shares of the Issuer that were automatically converted in connection with the Issuer's initial public offering from Class A Common Units of West Affum Holdings, L.P. previously held by the Reporting Person which were originally granted on October 7, 2024. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares will vest on October 7, 2025, 4,331 restricted common shares will vest on October 7, 2026 and 4,332 restricted common shares will vest on October 7, 2027.

SEC source: 0000950170-25-113631 · ownership.xml · nonDerivative · entry 2

COHEN RAYMOND W · CIK 0001258288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,903

F2 · shares: The reported securities in this row represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

F2 · price: The reported securities in this row represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

SEC source: 0000950170-25-113623 · ownership.xml · nonDerivative · entry 1

Kwo Elizabeth · CIK 0001820001 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,909

F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date.

SEC source: 0000950170-25-098339 · ownership.xml · nonDerivative · entry 1

COHEN RAYMOND W · CIK 0001258288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,994

F1 · date: The Reporting Person previously held restricted Class A Common Units of West Affum Holdings, L.P. granted on July 24, 2024, which were automatically converted into 12,994 restricted common shares of the Issuer in connection with the Issuer's initial public offering. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares held by the Reporting Person vested on July 24, 2025. Of the remaining restricted common shares held by the Reporting Person, 4,331 restricted common shares will vest on July 24, 2026 and 4,332 restricted common shares will vest on July 24, 2027.

F1 · price: The Reporting Person previously held restricted Class A Common Units of West Affum Holdings, L.P. granted on July 24, 2024, which were automatically converted into 12,994 restricted common shares of the Issuer in connection with the Issuer's initial public offering. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares held by the Reporting Person vested on July 24, 2025. Of the remaining restricted common shares held by the Reporting Person, 4,331 restricted common shares will vest on July 24, 2026 and 4,332 restricted common shares will vest on July 24, 2027.

SEC source: 0000950170-25-097326 · ownership.xml · nonDerivative · entry 1

Webster Brian Daniel · CIK 0001877188 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 397,577

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 29,333 on July 17, 2026, 29,333 on July 17, 2027 and 29,334 on July 17, 2028.

SEC source: 0000950170-25-097321 · ownership.xml · nonDerivative · entry 1

Mahboob Vaseem · CIK 0001655157 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,897

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 7,353 on July 17, 2026, 7,353 on July 17, 2027 and 7,354 on July 17, 2028.

SEC source: 0000950170-25-097318 · ownership.xml · nonDerivative · entry 1

Umberger Traci S · CIK 0001877198 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,836

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 9,804 on July 17, 2026, 9,804 on July 17, 2027 and 9,804 on July 17, 2028.

SEC source: 0000950170-25-097312 · ownership.xml · nonDerivative · entry 1

Ford Alfred J Jr · CIK 0001359446 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,412

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSU's will vest 9,804 on July 17, 2026, 9,804 on July 17, 2027 and 9,804 on July 17, 2028.

SEC source: 0000950170-25-113631 · ownership.xml · nonDerivative · entry 1

COHEN RAYMOND W · CIK 0001258288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,994

F1 · shares: The reported securities in this row were purchased in connection with the Issuer's initial public offering reserved share program and were inadvertently omitted from the Reporting Person's prior filings.

SEC source: 0001193125-25-203649 · ownership.xml · nonDerivative · entry 1

Ford Alfred J Jr · CIK 0001359446 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,412

F1 · shares: The reported securities were purchased in connection with the Issuer's initial public offering reserved share program and were inadvertently omitted from the Reporting Person's prior filings.

SEC source: 0001193125-25-203592 · ownership.xml · nonDerivative · entry 1

Umberger Traci S · CIK 0001877198 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,336

F1 · shares: The reported securities were purchased in connection with the Issuer's initial public offering reserved share program and were inadvertently omitted from the Reporting Person's prior filings.